Organogenesis Holdings (ORGO) Competitor Comparison
We are evaluating the key criteria listed to compare Organogenesis Holdings (ORGO) against its competitors in the Drug Manufacturers - Specialty & Generic industry.
Market Capitalization
27 / 54Gross Profits
14 / 39Total Revenue
25 / 50EBITDA
25 / 53Free Cashflow
35 / 54Quick Ratio
17 / 54Earnings per Share
22 / 54Dividend yield
0 / 5Total Cash
26 / 54Performance 3 years
36 / 54Performance 5 years
26 / 54Performance 10 years
29 / 54Linearity 3 years
36 / 54Linearity 5 years
23 / 54Linearity 10 years
20 / 54Total Rank
9 / 54Dividend Rank
14 / 54Valuation Rank
24 / 54Piotroski Rank
4 / 54Muliplier Rank
25 / 54Dividend Rank - ORGO ranking 14 / 54
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.